Vanja Zeremski

Leipziger Str. 44
Magdeburg, ST 39120, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Response-adapted consolidation and salvage strategies in secondary central nervous system lymphoma: Insights from a multicentre cohort.

Response-adapted consolidation and salvage strategies in secondary central nervous system lymphoma: Insights from a multicentre cohort.

Journal: British journal of haematology

Published: March 31, 2026

Epcoritamab in Richter transformation: insights from a real-world case series.

Epcoritamab in Richter transformation: insights from a real-world case series.

Journal: Blood advances

Published: March 18, 2026

Epcoritamab in Richter Transformation: Insights from a Real-World Case Series.

Epcoritamab in Richter Transformation: Insights from a Real-World Case Series.

Journal: Blood advances

Published: March 18, 2026

Unraveling the immune microenvironment in primary CNS lymphoma.

Unraveling the immune microenvironment in primary CNS lymphoma.

Journal: Biomarker research

Published: February 11, 2026

Outcomes of real-world complete responders after fixed-duration glofitamab in relapsed/refractory large B-cell lymphoma.

Outcomes of real-world complete responders after fixed-duration glofitamab in relapsed/refractory large B-cell lymphoma.

Journal: Haematologica

Published: October 17, 2025

Outcomes of real-world complete responders after fixed-duration glofitamab in relapsed/refractory large B-cell lymphoma.

Outcomes of real-world complete responders after fixed-duration glofitamab in relapsed/refractory large B-cell lymphoma.

Journal: Haematologica

Published: October 17, 2025

Early CAR T-cell therapy in relapsed/refractory large B-cell lymphoma is associated with lower hematotoxicity burden.

Early CAR T-cell therapy in relapsed/refractory large B-cell lymphoma is associated with lower hematotoxicity burden.

Journal: Blood advances

Published: September 15, 2025

Early CAR T-cell therapy in relapsed/refractory large B-cell lymphoma is associated with lower hematotoxicity burden.

Early CAR T-cell therapy in relapsed/refractory large B-cell lymphoma is associated with lower hematotoxicity burden.

Journal: Blood advances

Published: September 15, 2025

PFS24 as a prognostic milestone in patients with newly diagnosed primary CNS lymphoma.

PFS24 as a prognostic milestone in patients with newly diagnosed primary CNS lymphoma.

Journal: Journal of hematology & oncology

Published: February 10, 2025

Efficacy and safety of first-line high-dose cytarabine in patients with primary CNS lymphoma ineligible for high-dose methotrexate: A case series.

Efficacy and safety of first-line high-dose cytarabine in patients with primary CNS lymphoma ineligible for high-dose methotrexate: A case series.

Journal: Neuro-oncology practice

Published: February 07, 2025

Hypogammaglobulinemia and Anti-CD20 Therapy-Induced Acute Thrombocytopenia: Perhaps More than a Coincidence?

Hypogammaglobulinemia and Anti-CD20 Therapy-Induced Acute Thrombocytopenia: Perhaps More than a Coincidence?

Journal: Oncology research and treatment

Published: April 09, 2024

Increased PD-1 Expression on Circulating T Cells Correlates with Inferior Outcome after Autologous Stem Cell Transplantation.

Increased PD-1 Expression on Circulating T Cells Correlates with Inferior Outcome after Autologous Stem Cell Transplantation.

Journal: Transplantation and cellular therapy

Published: November 16, 2023

Showing 1-12 of 34

Last Updated: 09/26/2026